2010: The evaluation of clinical relevance in benefit assessments

It is a well-known and recognized requirement that in clinical trials, in addition to evaluating (statistical) significance, the (clinical) relevance of results should also be evaluated. This year "IQWiG in dialogue” therefore deals with the approach to such an evaluation within the framework of systematic reviews and its importance to the approval of drugs, as well as to the conduct and assessment of clinical trials.

On 18 June 2010, 155 participants discussed the necessity, methods and consequences of relevance assessments with representatives from IQWiG, regulatory authorities, universities and industry.